Mostaganem

Researchers are describing the demographic, epidemiological, clinical, and outcome characteristics of patients diagnosed with prostate cancer in Algeria. The study also analyzes the diagnostic methods and treatment approaches used for managing these patients. This is a descriptive, cross-sectional clinical study including patients with histologically or biologically confirmed prostate cancer. The study plans to enroll 500 patients who are being followed in participating oncology centers. Data collection involves reviewing medical records and conducting structured patient interviews lasting approximately 30 minutes. A standardized electronic case report form is used to ensure data completeness and accuracy. Information gathered includes sociodemographic details, medical history, disease characteristics, diagnostic tests performed, and treatments implemented. Participants are evaluated at the initial visit with assessments including socio-demographic factors, personal and family cancer history, environmental and occupational exposures, smoking and alcohol use, initial symptoms, and diagnosis circumstances. The International Prostate Symptom Score (IPSS) and disease status are also recorded. All collected data is anonymized and used solely for research. The study focuses on baseline characteristics without interventional treatments or long-term follow-up described.